Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Pastorelli

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Gastroenterology and Hepatology|June 23, 2021
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapySandro Ardizzone, Francesca Ferretti, Maria Camilla Monico, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 23, 2021
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control populationGiovanni Maconi, Cristina Bosetti, Alberta De Monti, et al.
Computer Methods and Programs in Biomedicine|July 17, 2022
Constrained multiple instance learning for ulcerative colitis prediction using histological imagesRocío Del Amor, Pablo Meseguer, Tommaso Lorenzo Parigi, et al.
United European Gastroenterology Journal|February 23, 2022
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitisOlga Maria Nardone, Alina Bazarova, Pradeep Bhandari, et al.
Gut|May 2, 2020
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyCristina Bezzio, Simone Saibeni, Angela Variola, et al.
Gastroenterology|December 21, 2020
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative ColitisMarietta Iacucci, Samuel C L Smith, Alina Bazarova, et al.
Gut|February 17, 2022
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence systemXianyong Gui, Alina Bazarova, Rocìo Del Amor, et al.
Gastroenterology|March 5, 2023
Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative ColitisMarietta Iacucci, Tommaso Lorenzo Parigi, Rocio Del Amor, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison studyAndrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, et al.
BMC Gastroenterology|July 5, 2023
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic wavesCristina Bezzio, Marta Vernero, Stefania Costa, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Gastroenterology and Hepatology|June 23, 2021
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapySandro Ardizzone, Francesca Ferretti, Maria Camilla Monico, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 23, 2021
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control populationGiovanni Maconi, Cristina Bosetti, Alberta De Monti, et al.
Computer Methods and Programs in Biomedicine|July 17, 2022
Constrained multiple instance learning for ulcerative colitis prediction using histological imagesRocío Del Amor, Pablo Meseguer, Tommaso Lorenzo Parigi, et al.
United European Gastroenterology Journal|February 23, 2022
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitisOlga Maria Nardone, Alina Bazarova, Pradeep Bhandari, et al.
Gut|May 2, 2020
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyCristina Bezzio, Simone Saibeni, Angela Variola, et al.
Gastroenterology|December 21, 2020
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative ColitisMarietta Iacucci, Samuel C L Smith, Alina Bazarova, et al.
Gut|February 17, 2022
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence systemXianyong Gui, Alina Bazarova, Rocìo Del Amor, et al.
Gastroenterology|March 5, 2023
Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative ColitisMarietta Iacucci, Tommaso Lorenzo Parigi, Rocio Del Amor, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison studyAndrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, et al.
BMC Gastroenterology|July 5, 2023
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic wavesCristina Bezzio, Marta Vernero, Stefania Costa, et al.
Pageof 8